The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
Posted inBusiness
Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits
